about
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusThe peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectinChromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsIFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosusRequirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexesMurine B cell response to TLR7 ligands depends on an IFN-beta feedback loopFas and Fas ligand in autoimmunity.The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity.Toll-like receptors, endogenous ligands, and systemic autoimmune disease.Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivoRole for interferon regulatory factors in autoimmunity.Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects.Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate bindersGrowth hormone binding protein in patients with renal failureArteriovenous fistulas in renal transplants: color Doppler ultrasound observationsKinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary cultureThe immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell culturesAnti-neutrophil cytoplasm antibodies (ANCA) increase neutrophil adhesion to cultured human endotheliumEffect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophilsT-bet: the Toll-bridge to class-switch recombination?Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibodyImmune complexes present in the sera of autoimmune mice activate rheumatoid factor B cellsAcceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alphaA 57-year-old woman with recently diagnosed SLE, proteinuria, and microhematuriaDNA and RNA autoantigens as autoadjuvantsMurine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 productionLupus nephritis
P50
Q28486062-59182A7F-0D9E-43F8-BE75-9C37965E244AQ28585701-B21EF39C-AB63-45FD-B902-D8B796B8CDC9Q29615065-04B045F8-C082-4DBF-AF43-196A1C384A03Q33804141-5DD0DFBE-085B-420B-ACA1-FDD006DBC42CQ33815085-2E58DCED-4283-4083-B9A4-9940ABF44C5BQ34090517-547BF6C2-E79B-4A7A-B846-2CBDD7E278F9Q34494364-8DA6D271-B7BC-46FC-9001-26C78A688BE2Q35839773-019FBF36-0502-4417-8871-7E9FE00FD733Q36079856-2B85BFA1-6ACE-4FC6-8306-7912347D7CF2Q36402668-57987EFD-7A1C-40BE-A75C-2E205794CA55Q36403678-A1BDBE5E-B5AF-48E8-9DAA-23A640F0F4B9Q36766872-3C342043-6591-4C57-B94C-7955F9254D56Q37270799-89A2FB9B-19DA-4737-A8D0-62941DDDA6A1Q37791652-B76F0499-A1A1-4DC0-B07D-657563E600BEQ38336526-9D3FC31D-89C3-4D21-A361-7621D408D8ACQ43097078-F3365BC8-C8BA-4F33-A130-E25B459B2321Q57226269-B05CAD5A-7449-4D5D-9332-7D5CAFCA7656Q68001127-66DED35D-B0D1-4723-B3D5-48985B250868Q68144024-0271F3F4-2F0B-4F0A-9689-85C52B791817Q71118270-CC7423A6-C681-4F2A-9EB8-BD55762C2781Q72533159-223EABE3-F8D6-4F58-B1EE-3CE90B9808CCQ72666020-6F7C9ACC-5AC7-4EA1-A20B-1F0927FEA134Q72672581-6C404E5F-05F0-4586-A0D8-B4BD3394EC92Q73582970-A327A654-753B-4CDD-8364-75D052D7C08EQ74013051-4624DD19-88CE-4987-88F4-52B97F3B700AQ74027261-94E85F00-F558-4909-8C54-5A2F0445FA19Q77573800-5C485CF5-2E11-4642-946F-9B2C72A6FB00Q79426661-6F714652-5068-4EFC-B9AC-B42FCFFCCC3CQ79663762-0DE14AA6-994A-43AD-A29E-5A1E422D1F57Q80358480-FCA200DE-760C-4C01-9C29-08AF228BB83BQ82792686-D78B628C-8A81-4A44-9649-BFC8252C4C52
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ian R Rifkin
@ast
Ian R Rifkin
@en
Ian R Rifkin
@es
Ian R Rifkin
@nl
Ian R Rifkin
@sl
type
label
Ian R Rifkin
@ast
Ian R Rifkin
@en
Ian R Rifkin
@es
Ian R Rifkin
@nl
Ian R Rifkin
@sl
prefLabel
Ian R Rifkin
@ast
Ian R Rifkin
@en
Ian R Rifkin
@es
Ian R Rifkin
@nl
Ian R Rifkin
@sl
P106
P31
P496
0000-0002-2674-3991